-
Je něco špatně v tomto záznamu ?
Cytotoxicity and effects on inflammatory response of modified types of cellulose in macrophage-like THP-1 cells
P. Kollar, V. Závalová, J. Hošek, P. Havelka, T. Sopuch, M. Karpíšek, D. Třetinová, P. Suchý
Jazyk angličtina Země Nizozemsko
Typ dokumentu časopisecké články, práce podpořená grantem
Odkazy
PubMed
21354485
DOI
10.1016/j.intimp.2011.02.016
Knihovny.cz E-zdroje
- MeSH
- akutní monocytární leukemie MeSH
- buňky - růstové procesy účinky léků MeSH
- celulosa analogy a deriváty farmakologie MeSH
- hojení ran účinky léků imunologie MeSH
- lidé MeSH
- lipopolysacharidy farmakologie MeSH
- makrofágy účinky léků imunologie MeSH
- nádorové buněčné linie MeSH
- TNF-alfa biosyntéza genetika MeSH
- tristetraprolin biosyntéza genetika MeSH
- zánět farmakoterapie imunologie patologie MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
The cytotoxicity and in vitro effects of six variously modified types of cellulose (OC--oxidized cellulose, NaOC--oxidized cellulose sodium salt, DAC--dialdehyde cellulose, CMC--carboxymethyl cellulose, MFC--microfibrilated cellulose, and MCC--microcrystalline cellulose) on the inflammatory response in macrophage-like THP-1 cells were examined, with special focus on their ability to influence gene expression and the production of TNF-α. The study provides evidence that DAC exerts a marked effect on the induction of TNF-α gene expression and its subsequent production in human macrophages. Thus, the use of DAC for anti-hemorrhagic or wound-healing therapy should be considered carefully with regard to its pro-inflammatory activity. On the contrary, MCC showed significant anti-inflammatory effects in the LPS-induced conditions, which might be beneficial for the treatment of non-healing chronic wounds, e.g., diabetic or venous ulcers.
- 000
- 00000naa a2200000 a 4500
- 001
- bmc12022312
- 003
- CZ-PrNML
- 005
- 20160405160849.0
- 007
- ta
- 008
- 120806s2011 ne f 000 0#eng||
- 009
- AR
- 024 7_
- $a 10.1016/j.intimp.2011.02.016 $2 doi
- 035 __
- $a (PubMed)21354485
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a ne
- 100 1_
- $a Kollár, Peter $7 xx0106036 $u Department of Human Pharmacology and Toxicology, Faculty of Pharmacy, University of Veterinary and Pharmaceutical Sciences Brno, Palackého 1-3, CZ-612 42 Brno, Czech Republic. kollarp@vfu.cz
- 245 10
- $a Cytotoxicity and effects on inflammatory response of modified types of cellulose in macrophage-like THP-1 cells / $c P. Kollar, V. Závalová, J. Hošek, P. Havelka, T. Sopuch, M. Karpíšek, D. Třetinová, P. Suchý
- 520 9_
- $a The cytotoxicity and in vitro effects of six variously modified types of cellulose (OC--oxidized cellulose, NaOC--oxidized cellulose sodium salt, DAC--dialdehyde cellulose, CMC--carboxymethyl cellulose, MFC--microfibrilated cellulose, and MCC--microcrystalline cellulose) on the inflammatory response in macrophage-like THP-1 cells were examined, with special focus on their ability to influence gene expression and the production of TNF-α. The study provides evidence that DAC exerts a marked effect on the induction of TNF-α gene expression and its subsequent production in human macrophages. Thus, the use of DAC for anti-hemorrhagic or wound-healing therapy should be considered carefully with regard to its pro-inflammatory activity. On the contrary, MCC showed significant anti-inflammatory effects in the LPS-induced conditions, which might be beneficial for the treatment of non-healing chronic wounds, e.g., diabetic or venous ulcers.
- 650 _2
- $a buňky - růstové procesy $x účinky léků $7 D048708
- 650 _2
- $a nádorové buněčné linie $7 D045744
- 650 _2
- $a celulosa $x analogy a deriváty $x farmakologie $7 D002482
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a zánět $x farmakoterapie $x imunologie $x patologie $7 D007249
- 650 _2
- $a akutní monocytární leukemie $7 D007948
- 650 _2
- $a lipopolysacharidy $x farmakologie $7 D008070
- 650 _2
- $a makrofágy $x účinky léků $x imunologie $7 D008264
- 650 _2
- $a tristetraprolin $x biosyntéza $x genetika $7 D051816
- 650 _2
- $a TNF-alfa $x biosyntéza $x genetika $7 D014409
- 650 _2
- $a hojení ran $x účinky léků $x imunologie $7 D014945
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Závalová, Veronika $u Department of Human Pharmacology and Toxicology, Faculty of Pharmacy, University of Veterinary and Pharmaceutical Sciences Brno, Palackého 1-3, CZ-612 42 Brno, Czech Republic
- 700 1_
- $a Hošek, Jan $7 xx0106185 $u Department of Natural Drugs, Faculty of Pharmacy, University of Veterinary and Pharmaceutical Sciences Brno, Palackého 1-3, CZ-612 42 Brno, Czech Republic
- 700 1_
- $a Havelka, Pavel $7 _BN002434 $u VUOS a.s., Rybitví 296, CZ-533 54 Rybitví, Czech Republic
- 700 1_
- $a Sopuch, Tomáš $7 xx0140706 $u Synthesia, a.s., Pardubice – Semtín 103, CZ-532 17 Pardubice, Czech Republic
- 700 1_
- $a Karpíšek, Michal $7 xx0107472 $u Department of Human Pharmacology and Toxicology, Faculty of Pharmacy, University of Veterinary and Pharmaceutical Sciences Brno, Palackého 1-3, CZ-612 42 Brno, Czech Republic
- 700 1_
- $a Třetinová, Dominika $u Department of Human Pharmacology and Toxicology, Faculty of Pharmacy, University of Veterinary and Pharmaceutical Sciences Brno, Palackého 1-3, CZ-612 42 Brno, Czech Republic
- 700 1_
- $a Suchý, Pavel, $d 1970- $7 mzk2008448769 $u Department of Human Pharmacology and Toxicology, Faculty of Pharmacy, University of Veterinary and Pharmaceutical Sciences Brno, Palackého 1-3, CZ-612 42 Brno, Czech Republic
- 773 0_
- $w MED00006034 $t International immunopharmacology $x 1878-1705 $g Roč. 11, č. 8 (2011), s. 997-1001
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/21354485 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y m $z 0
- 990 __
- $a 20120806 $b ABA008
- 991 __
- $a 20160405160925 $b ABA008
- 999 __
- $a ok $b bmc $g 944225 $s 779609
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2011 $b 11 $c 8 $d 997-1001 $e 20110226 $i 1878-1705 $m International immunopharmacology $n Int Immunopharmacol $x MED00006034
- LZP __
- $b NLK111 $a Pubmed-20120806/12/01